FDA — authorised 22 August 1977
- Marketing authorisation holder: PROMIUS PHARMA LLC
- Status: approved
🇺🇸 Cloderm in United States
FDA authorised Cloderm on 22 August 1977
Marketing authorisations
FDA — authorised 22 August 1977
- Application: NDA017765
- Marketing authorisation holder: LEGACY PHARMA
- Local brand name: CLODERM
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 21 April 2020
- Application: ANDA206370
- Marketing authorisation holder: TARO
- Local brand name: CLOCORTOLONE PIVALATE
- Indication: CREAM — TOPICAL
- Status: approved
Cloderm in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Cloderm approved in United States?
Yes. FDA authorised it on 22 August 1977; FDA authorised it on 22 August 1977; FDA authorised it on 21 April 2020.
Who is the marketing authorisation holder for Cloderm in United States?
PROMIUS PHARMA LLC holds the US marketing authorisation.